Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12104/40461
Title: CYP1A1 *2B and *4 polymorphisms are associated with lung cancer susceptibility in Mexican patients
Author: Gallegos-Arreola, M.P.
Figuera-Villanueva, L.E.
Troyo-Sanroman, R.
Morgan-Villela, G.
Puebla-Perez, A.M.
Flores-Marquez, M.R.
Zuniga-Gonzalez, G.M.
Issue Date: 2008
Abstract: Background: CYP1A1 is a gene involved in the high aryl hydrocarbon hydroxylase -inducible phenotype, which is a genetically-determined variation among individuals that has been associated with lung cancer risk. More specifically, CYP1A1*2B and *4 polymorphisms have been associated with high susceptibility to lung cancer among cigarette smokers. Materials and methods: DNA was obtained from blood samples and we studied by PCR-RFLP the distribution of CYP1A1*2B (n=248) and *4 (n=222) polymorphisms in healthy controls and 222 lung cancer patients from a Mexican population. Results: Comparisons between groups showed an increased risk for lung cancer patients of *2B/*2B (18%; OR 7.6; 95% CI 3.0-19.2) and *4/*4 genotypes (15%; OR 11.45; 95% CI 2.19-59.85) compared to the control group (1% for *2B/*2B and 4.4% for *4/*4). A significant association between lung cancer and homozygous ?2B/*2B passive smokers and *4/*4 ever (cigarettes) and passive smokers was also observed (p<0.05). Multivariate analysis revealed an increased risk for the *2B/2B genotype (OR 6.83), as well as for *4/*4 (OR 28.8). Conclusion: The results of the study indicate a significant association between *2B/*2B and *4/*4 genotypes and the risk of developing lung cancer among Mexicans. � 2008 Wichtig Editore.
URI: http://www.scopus.com/inward/record.url?eid=2-s2.0-44149125773&partnerID=40&md5=6a567cc280848e97a5ee034327bb9d64
http://hdl.handle.net/20.500.12104/40461
Appears in Collections:Producción científica UdeG

Files in This Item:
There are no files associated with this item.


Items in RIUdeG are protected by copyright, with all rights reserved, unless otherwise indicated.